PISCOM. A new procedure for epilepsy combining ictal SPECT and interictal PET
Creators
- Perissinotti, Andres1
- Mayoral, Maria1
- Sanchez-Izquierdo, Nuria1
- Lomena, Francisco1
- Ninerola-Baizan, Aida2, 3
- Marti-Fuster, Berta2, 3
- Ros, Domenec2, 3
- Rubi, Sebastia4, 5
- Carreno, Mar6
- Donaire, Antonio6
- Aparicio, Javier7
- Bargallo, Nuria8
- Rumia, Jordi9
- Boget, Teresa10
- Pons, Francesca2, 1
- Pavia, Javier3, 1
- Setoain, Xavier2, 3, 1
- 1. Hospital Clinic, Department of Nuclear Medicine, Barcelona (Spain)
- 2. University of Barcelona, Barcelona (Spain)
- 3. Biomaterials and Nanomedicine (CIBER-BBN), Biomedical Research Networking Center in Bioengineering, Barcelona (Spain)
- 4. Institut d'Investigacio Sanitaria Illes Balears (IdISBa), Palma (Spain)
- 5. Hospital Universitari Son Espases, Nuclear Medicine Department, Palma (Spain)
- 6. Hospital Clinic, Department of Neurology, Barcelona (Spain)
- 7. Hospital Sant Joan de Deu, Department of Neurology, Barcelona (Spain)
- 8. Hospital Clinic, Department of Radiology, Barcelona (Spain)
- 9. Hospital Clinic, Department of Neurosurgery, Barcelona (Spain)
- 10. Hospital Clinic, Department of Psychiatry and Psychology, Barcelona (Spain)
Description
We present a modified version of the SISCOM procedure that uses interictal PET instead of interictal SPECT for seizure onset zone localization. We called this new nuclear imaging processing technique PISCOM (PET interictal subtracted ictal SPECT coregistered with MRI). We retrospectively studied 23 patients (age range 4-61 years) with medically refractory epilepsy who had undergone MRI, ictal SPECT, interictal SPECT and interictal FDG PET and who had been seizure-free for at least 2 years after surgical treatment. FDG PET images were reprocessed (rFDG PET) to assimilate SPECT features for image subtraction. Interictal SPECT and rFDG PET were compared using statistical parametric mapping (SPM). PISCOM and SISCOM images were evaluated visually and using an automated volume of interest-based analysis. The results of the two studies were compared with each other and with the known surgical resection site. SPM showed no significant differences in cortical activity between SPECT and rFDG PET images. PISCOM and SISCOM showed equivalent results in 17 of 23 patients (74%). The seizure onset zone was successfully identified in 19 patients (83%) by PISCOM and in 17 (74%) by SISCOM: in 15 patients (65%) the two techniques showed concordant successful results. The volume of interest-based analysis showed no significant differences between PISCOM and SISCOM in identifying the extension of the seizure onset zone. However, PISCOM showed a lower amount of indeterminate activity due to propagation, background or artefacts. Preliminary findings of this initial proof-of-concept study suggest that perfusion and glucose metabolism in the cerebral cortex can be correlated and that PISCOM may be a valid technique for identification of the seizure onset zone. However, further studies are needed to validate these results. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-018-4080-6Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 45
- Journal Issue
- 13
- Journal Page Range
- p. 2358-2367
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 50004186
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ACTIVITY LEVELS; BLOOD FLOW; CEREBRAL CORTEX; COMPUTERIZED TOMOGRAPHY; EPILEPSY; FLUORINE 18; FLUORODEOXYGLUCOSE; HISTOLOGY; IMAGE PROCESSING; IMAGE SCANNERS; MAGNETIC FIELDS; MAPPING; NMR IMAGING; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SURGERY; TECHNETIUM 99; UPTAKE; VALIDATION
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBRUM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANS; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; TECHNETIUM ISOTOPES; TESTING; TOMOGRAPHY; YEARS LIVING RADIOISOTOPES